Cargando…
Proteolysis-targeting chimeras and their implications in breast cancer
Breast cancer (BC) is a highly heterogeneous neoplasm of the mammary tissue, causing the deaths of a large number of women worldwide. Nearly 70% and 20% of BC cases are estrogen receptor alpha positive (ERα+) and human epidermal growth factor receptor 2-positive (HER2+), respectively; therefore, ER...
Autores principales: | Tecalco-Cruz, Angeles C., Zepeda-Cervantes, Jesús, Ramírez-Jarquín, Josué O., Rojas-Ochoa, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400758/ https://www.ncbi.nlm.nih.gov/pubmed/36046115 http://dx.doi.org/10.37349/etat.2021.00060 |
Ejemplares similares
-
Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2018) -
Epigenetic basis of Alzheimer disease
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2020) -
Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2022) -
Protein ISGylation: a posttranslational modification with implications for malignant neoplasms
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2023) -
Proteolysis targeting chimeras (PROTACs) in cancer therapy
por: Ocaña, Alberto, et al.
Publicado: (2020)